nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—SLCO4C1—Methotrexate—ankylosing spondylitis	0.362	0.421	CbGbCtD
Saxagliptin—ABCC1—Methotrexate—ankylosing spondylitis	0.0983	0.114	CbGbCtD
Saxagliptin—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0908	0.105	CbGbCtD
Saxagliptin—SLC22A8—Methotrexate—ankylosing spondylitis	0.0764	0.0887	CbGbCtD
Saxagliptin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0467	0.0542	CbGbCtD
Saxagliptin—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0453	0.0526	CbGbCtD
Saxagliptin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0354	0.0411	CbGbCtD
Saxagliptin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0304	0.0353	CbGbCtD
Saxagliptin—CYP3A4—Prednisolone—ankylosing spondylitis	0.03	0.0348	CbGbCtD
Saxagliptin—CYP3A4—Prednisone—ankylosing spondylitis	0.0283	0.0329	CbGbCtD
Saxagliptin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0177	0.0205	CbGbCtD
Saxagliptin—Tuberculosis—Dexamethasone—ankylosing spondylitis	0.00703	0.0509	CcSEcCtD
Saxagliptin—Tuberculosis—Betamethasone—ankylosing spondylitis	0.00703	0.0509	CcSEcCtD
Saxagliptin—Tuberculosis—Prednisone—ankylosing spondylitis	0.00612	0.0443	CcSEcCtD
Saxagliptin—Immunodeficiency—Methotrexate—ankylosing spondylitis	0.00539	0.039	CcSEcCtD
Saxagliptin—Opportunistic infection—Methylprednisolone—ankylosing spondylitis	0.0035	0.0254	CcSEcCtD
Saxagliptin—Opportunistic infection—Dexamethasone—ankylosing spondylitis	0.00319	0.0231	CcSEcCtD
Saxagliptin—Opportunistic infection—Betamethasone—ankylosing spondylitis	0.00319	0.0231	CcSEcCtD
Saxagliptin—Pancreatitis acute—Dexamethasone—ankylosing spondylitis	0.00278	0.0201	CcSEcCtD
Saxagliptin—Pancreatitis acute—Betamethasone—ankylosing spondylitis	0.00278	0.0201	CcSEcCtD
Saxagliptin—Opportunistic infection—Prednisone—ankylosing spondylitis	0.00278	0.0201	CcSEcCtD
Saxagliptin—Multiple fractures—Methylprednisolone—ankylosing spondylitis	0.00243	0.0176	CcSEcCtD
Saxagliptin—Fracture—Methylprednisolone—ankylosing spondylitis	0.00243	0.0176	CcSEcCtD
Saxagliptin—Pancreatitis acute—Prednisone—ankylosing spondylitis	0.00242	0.0175	CcSEcCtD
Saxagliptin—Opportunistic infection—Methotrexate—ankylosing spondylitis	0.00232	0.0168	CcSEcCtD
Saxagliptin—Fracture—Dexamethasone—ankylosing spondylitis	0.00221	0.016	CcSEcCtD
Saxagliptin—Fracture—Betamethasone—ankylosing spondylitis	0.00221	0.016	CcSEcCtD
Saxagliptin—Multiple fractures—Dexamethasone—ankylosing spondylitis	0.00221	0.016	CcSEcCtD
Saxagliptin—Multiple fractures—Betamethasone—ankylosing spondylitis	0.00221	0.016	CcSEcCtD
Saxagliptin—Lymphopenia—Prednisone—ankylosing spondylitis	0.00218	0.0158	CcSEcCtD
Saxagliptin—Hypertriglyceridaemia—Prednisone—ankylosing spondylitis	0.00195	0.0141	CcSEcCtD
Saxagliptin—Fracture—Prednisone—ankylosing spondylitis	0.00192	0.0139	CcSEcCtD
Saxagliptin—Multiple fractures—Prednisone—ankylosing spondylitis	0.00192	0.0139	CcSEcCtD
Saxagliptin—Blood triglycerides increased—Prednisone—ankylosing spondylitis	0.00171	0.0123	CcSEcCtD
Saxagliptin—Multiple fractures—Methotrexate—ankylosing spondylitis	0.00161	0.0116	CcSEcCtD
Saxagliptin—Fracture—Methotrexate—ankylosing spondylitis	0.00161	0.0116	CcSEcCtD
Saxagliptin—Purpura—Triamcinolone—ankylosing spondylitis	0.00107	0.00771	CcSEcCtD
Saxagliptin—Pancreatitis—Prednisolone—ankylosing spondylitis	0.000946	0.00685	CcSEcCtD
Saxagliptin—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.00087	0.0063	CcSEcCtD
Saxagliptin—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.000868	0.00628	CcSEcCtD
Saxagliptin—Purpura—Prednisone—ankylosing spondylitis	0.000842	0.00609	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.000825	0.00597	CcSEcCtD
Saxagliptin—Infestation—Methylprednisolone—ankylosing spondylitis	0.00079	0.00571	CcSEcCtD
Saxagliptin—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00079	0.00571	CcSEcCtD
Saxagliptin—Face oedema—Prednisone—ankylosing spondylitis	0.000783	0.00567	CcSEcCtD
Saxagliptin—Pancreatitis—Prednisone—ankylosing spondylitis	0.000688	0.00498	CcSEcCtD
Saxagliptin—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000646	0.00467	CcSEcCtD
Saxagliptin—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00064	0.00463	CcSEcCtD
Saxagliptin—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000617	0.00446	CcSEcCtD
Saxagliptin—Angioedema—Prednisolone—ankylosing spondylitis	0.000615	0.00445	CcSEcCtD
Saxagliptin—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000575	0.00416	CcSEcCtD
Saxagliptin—Angioedema—Triamcinolone—ankylosing spondylitis	0.000565	0.00409	CcSEcCtD
Saxagliptin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000564	0.00408	CcSEcCtD
Saxagliptin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000549	0.00397	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000545	0.00394	CcSEcCtD
Saxagliptin—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00054	0.00391	CcSEcCtD
Saxagliptin—Myalgia—Triamcinolone—ankylosing spondylitis	0.000527	0.00381	CcSEcCtD
Saxagliptin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000525	0.0038	CcSEcCtD
Saxagliptin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000525	0.0038	CcSEcCtD
Saxagliptin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000523	0.00378	CcSEcCtD
Saxagliptin—Infestation—Methotrexate—ankylosing spondylitis	0.000523	0.00378	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000522	0.00377	CcSEcCtD
Saxagliptin—Angioedema—Dexamethasone—ankylosing spondylitis	0.000513	0.00371	CcSEcCtD
Saxagliptin—Angioedema—Betamethasone—ankylosing spondylitis	0.000513	0.00371	CcSEcCtD
Saxagliptin—Immune system disorder—Prednisone—ankylosing spondylitis	0.000507	0.00367	CcSEcCtD
Saxagliptin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000505	0.00365	CcSEcCtD
Saxagliptin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000504	0.00364	CcSEcCtD
Saxagliptin—Infection—Triamcinolone—ankylosing spondylitis	0.000501	0.00363	CcSEcCtD
Saxagliptin—Infection—Methylprednisolone—ankylosing spondylitis	0.0005	0.00362	CcSEcCtD
Saxagliptin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000489	0.00354	CcSEcCtD
Saxagliptin—Malnutrition—Prednisone—ankylosing spondylitis	0.000489	0.00354	CcSEcCtD
Saxagliptin—Myalgia—Betamethasone—ankylosing spondylitis	0.000478	0.00346	CcSEcCtD
Saxagliptin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000478	0.00346	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00046	0.00333	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000459	0.00332	CcSEcCtD
Saxagliptin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000458	0.00331	CcSEcCtD
Saxagliptin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000458	0.00331	CcSEcCtD
Saxagliptin—Infection—Dexamethasone—ankylosing spondylitis	0.000455	0.00329	CcSEcCtD
Saxagliptin—Infection—Betamethasone—ankylosing spondylitis	0.000455	0.00329	CcSEcCtD
Saxagliptin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000448	0.00324	CcSEcCtD
Saxagliptin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000448	0.00324	CcSEcCtD
Saxagliptin—Angioedema—Prednisone—ankylosing spondylitis	0.000447	0.00323	CcSEcCtD
Saxagliptin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000444	0.00321	CcSEcCtD
Saxagliptin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000443	0.00321	CcSEcCtD
Saxagliptin—Urticaria—Prednisolone—ankylosing spondylitis	0.000436	0.00315	CcSEcCtD
Saxagliptin—Fatigue—Triamcinolone—ankylosing spondylitis	0.000435	0.00315	CcSEcCtD
Saxagliptin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000434	0.00314	CcSEcCtD
Saxagliptin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000424	0.00307	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000417	0.00302	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000417	0.00302	CcSEcCtD
Saxagliptin—Myalgia—Prednisone—ankylosing spondylitis	0.000416	0.00301	CcSEcCtD
Saxagliptin—Arthralgia—Prednisone—ankylosing spondylitis	0.000416	0.00301	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000413	0.00299	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000412	0.00298	CcSEcCtD
Saxagliptin—Malnutrition—Methotrexate—ankylosing spondylitis	0.000408	0.00296	CcSEcCtD
Saxagliptin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000404	0.00293	CcSEcCtD
Saxagliptin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000403	0.00292	CcSEcCtD
Saxagliptin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000403	0.00292	CcSEcCtD
Saxagliptin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000401	0.0029	CcSEcCtD
Saxagliptin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0004	0.00289	CcSEcCtD
Saxagliptin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000399	0.00289	CcSEcCtD
Saxagliptin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000398	0.00288	CcSEcCtD
Saxagliptin—Infection—Prednisone—ankylosing spondylitis	0.000396	0.00287	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000395	0.00286	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000395	0.00286	CcSEcCtD
Saxagliptin—Fatigue—Betamethasone—ankylosing spondylitis	0.000395	0.00286	CcSEcCtD
Saxagliptin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000395	0.00286	CcSEcCtD
Saxagliptin—Skin disorder—Prednisone—ankylosing spondylitis	0.000387	0.0028	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000375	0.00271	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000375	0.00271	CcSEcCtD
Saxagliptin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000372	0.00269	CcSEcCtD
Saxagliptin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000371	0.00268	CcSEcCtD
Saxagliptin—Urticaria—Dexamethasone—ankylosing spondylitis	0.000364	0.00263	CcSEcCtD
Saxagliptin—Urticaria—Betamethasone—ankylosing spondylitis	0.000364	0.00263	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000363	0.00263	CcSEcCtD
Saxagliptin—Dizziness—Prednisolone—ankylosing spondylitis	0.000363	0.00263	CcSEcCtD
Saxagliptin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000362	0.00262	CcSEcCtD
Saxagliptin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000362	0.00262	CcSEcCtD
Saxagliptin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000362	0.00262	CcSEcCtD
Saxagliptin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000361	0.00261	CcSEcCtD
Saxagliptin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000357	0.00258	CcSEcCtD
Saxagliptin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000356	0.00258	CcSEcCtD
Saxagliptin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000351	0.00254	CcSEcCtD
Saxagliptin—Myalgia—Methotrexate—ankylosing spondylitis	0.000348	0.00252	CcSEcCtD
Saxagliptin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000348	0.00252	CcSEcCtD
Saxagliptin—Rash—Prednisolone—ankylosing spondylitis	0.000346	0.0025	CcSEcCtD
Saxagliptin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000346	0.0025	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000345	0.0025	CcSEcCtD
Saxagliptin—Fatigue—Prednisone—ankylosing spondylitis	0.000344	0.00249	CcSEcCtD
Saxagliptin—Headache—Prednisolone—ankylosing spondylitis	0.000344	0.00249	CcSEcCtD
Saxagliptin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000334	0.00241	CcSEcCtD
Saxagliptin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000333	0.00241	CcSEcCtD
Saxagliptin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000333	0.00241	CcSEcCtD
Saxagliptin—Infection—Methotrexate—ankylosing spondylitis	0.000331	0.0024	CcSEcCtD
Saxagliptin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000329	0.00238	CcSEcCtD
Saxagliptin—Asthenia—Betamethasone—ankylosing spondylitis	0.000329	0.00238	CcSEcCtD
Saxagliptin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000326	0.00236	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000326	0.00236	CcSEcCtD
Saxagliptin—Nausea—Prednisolone—ankylosing spondylitis	0.000326	0.00236	CcSEcCtD
Saxagliptin—Pruritus—Betamethasone—ankylosing spondylitis	0.000324	0.00234	CcSEcCtD
Saxagliptin—Pruritus—Dexamethasone—ankylosing spondylitis	0.000324	0.00234	CcSEcCtD
Saxagliptin—Skin disorder—Methotrexate—ankylosing spondylitis	0.000324	0.00234	CcSEcCtD
Saxagliptin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000321	0.00232	CcSEcCtD
Saxagliptin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00032	0.00232	CcSEcCtD
Saxagliptin—Rash—Triamcinolone—ankylosing spondylitis	0.000318	0.0023	CcSEcCtD
Saxagliptin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000318	0.0023	CcSEcCtD
Saxagliptin—Rash—Methylprednisolone—ankylosing spondylitis	0.000318	0.0023	CcSEcCtD
Saxagliptin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000317	0.0023	CcSEcCtD
Saxagliptin—Urticaria—Prednisone—ankylosing spondylitis	0.000317	0.00229	CcSEcCtD
Saxagliptin—Headache—Triamcinolone—ankylosing spondylitis	0.000316	0.00229	CcSEcCtD
Saxagliptin—Headache—Methylprednisolone—ankylosing spondylitis	0.000316	0.00228	CcSEcCtD
Saxagliptin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000315	0.00228	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000304	0.0022	CcSEcCtD
Saxagliptin—Dizziness—Betamethasone—ankylosing spondylitis	0.000303	0.00219	CcSEcCtD
Saxagliptin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000303	0.00219	CcSEcCtD
Saxagliptin—Nausea—Triamcinolone—ankylosing spondylitis	0.0003	0.00217	CcSEcCtD
Saxagliptin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000299	0.00216	CcSEcCtD
Saxagliptin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000294	0.00213	CcSEcCtD
Saxagliptin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000293	0.00212	CcSEcCtD
Saxagliptin—Vomiting—Betamethasone—ankylosing spondylitis	0.000291	0.00211	CcSEcCtD
Saxagliptin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000291	0.00211	CcSEcCtD
Saxagliptin—Rash—Betamethasone—ankylosing spondylitis	0.000289	0.00209	CcSEcCtD
Saxagliptin—Rash—Dexamethasone—ankylosing spondylitis	0.000289	0.00209	CcSEcCtD
Saxagliptin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000289	0.00209	CcSEcCtD
Saxagliptin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000289	0.00209	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000288	0.00208	CcSEcCtD
Saxagliptin—Fatigue—Methotrexate—ankylosing spondylitis	0.000287	0.00208	CcSEcCtD
Saxagliptin—Headache—Betamethasone—ankylosing spondylitis	0.000287	0.00208	CcSEcCtD
Saxagliptin—Headache—Dexamethasone—ankylosing spondylitis	0.000287	0.00208	CcSEcCtD
Saxagliptin—Asthenia—Prednisone—ankylosing spondylitis	0.000286	0.00207	CcSEcCtD
Saxagliptin—Pruritus—Prednisone—ankylosing spondylitis	0.000282	0.00204	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000273	0.00197	CcSEcCtD
Saxagliptin—Nausea—Betamethasone—ankylosing spondylitis	0.000272	0.00197	CcSEcCtD
Saxagliptin—Nausea—Dexamethasone—ankylosing spondylitis	0.000272	0.00197	CcSEcCtD
Saxagliptin—Urticaria—Methotrexate—ankylosing spondylitis	0.000265	0.00192	CcSEcCtD
Saxagliptin—Dizziness—Prednisone—ankylosing spondylitis	0.000264	0.00191	CcSEcCtD
Saxagliptin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000264	0.00191	CcSEcCtD
Saxagliptin—Vomiting—Prednisone—ankylosing spondylitis	0.000254	0.00183	CcSEcCtD
Saxagliptin—Rash—Prednisone—ankylosing spondylitis	0.000251	0.00182	CcSEcCtD
Saxagliptin—Dermatitis—Prednisone—ankylosing spondylitis	0.000251	0.00182	CcSEcCtD
Saxagliptin—Headache—Prednisone—ankylosing spondylitis	0.00025	0.00181	CcSEcCtD
Saxagliptin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000246	0.00178	CcSEcCtD
Saxagliptin—Asthenia—Methotrexate—ankylosing spondylitis	0.000239	0.00173	CcSEcCtD
Saxagliptin—Nausea—Prednisone—ankylosing spondylitis	0.000237	0.00171	CcSEcCtD
Saxagliptin—Pruritus—Methotrexate—ankylosing spondylitis	0.000236	0.00171	CcSEcCtD
Saxagliptin—Dizziness—Methotrexate—ankylosing spondylitis	0.00022	0.00159	CcSEcCtD
Saxagliptin—Vomiting—Methotrexate—ankylosing spondylitis	0.000212	0.00153	CcSEcCtD
Saxagliptin—Rash—Methotrexate—ankylosing spondylitis	0.00021	0.00152	CcSEcCtD
Saxagliptin—Dermatitis—Methotrexate—ankylosing spondylitis	0.00021	0.00152	CcSEcCtD
Saxagliptin—Headache—Methotrexate—ankylosing spondylitis	0.000209	0.00151	CcSEcCtD
Saxagliptin—Nausea—Methotrexate—ankylosing spondylitis	0.000198	0.00143	CcSEcCtD
